Congestive Heart Failure clinical trials

Explore recruiting congestive heart failure clinical trials.

Recruiting congestive heart failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Congestive Heart Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of combined diuretic therapy on exercise capacity, alveolar-capillary diffusion and maintenance of euvolemia in chronic congestive heart failure, diuretic therapy compared with loop diuretics and potassium-sparing diuretics

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Peritoneal Ultrafiltration in Cardio Renal Syndrome to Prevent Heart Failure Exacerbation (PURE)

Italy

Phase II and Phase III (Integrated) EU CTIS Study details

The effect of sacubitril/valsartan versus ramipril on left ventricular function and remodeling in patients with ischemic heart failure with mid-range ejection fraction.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

(ASK-CHF2-CS201) A Phase 2, adaptive, double-blinded, placebo-controlled, randomized, multi-center trial to evaluate the efficacy, safety and tolerability of intracoronary infusion of AB-1002 in adult subjects with New York Heart Association (NYHA) Class III heart failure and non-ischemic cardiomyopathy

Austria, Spain, Germany, Netherlands, Hungary, Belgium +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Achieve - ACetazolamide in patients with Heart failure, to decrease weight and relIEVE symptoms

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

LEVOMEMS: Comparison of the Hemodynamic Profile of Dobutamine and Levosimendan in the Current Therapeutic Context

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Congestive Heart Failure trials by city

Congestive Heart Failure in Toronto Congestive Heart Failure in Vancouver Congestive Heart Failure in Montreal Congestive Heart Failure in Calgary Congestive Heart Failure in Edmonton Congestive Heart Failure in Ottawa Congestive Heart Failure in Winnipeg Congestive Heart Failure in Quebec City Congestive Heart Failure in Hamilton Congestive Heart Failure in Kitchener Congestive Heart Failure in London Congestive Heart Failure in Halifax Congestive Heart Failure in New York Congestive Heart Failure in Los Angeles Congestive Heart Failure in Chicago Congestive Heart Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease